Related Articles
A new strategy using autologous dendritic cells and lymphokine-activated killer cells for cancer immunotherapy: efficient maturation of DCs by co-culture with LAK cells in vitro
Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: Possible application for compensatory anti-inflammatory response syndrome
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
INHIBITION OF PROLIFERATION, ACTIVATION AND FUNCTION OF HUMAN NATURAL-KILLER-CELLS IN-VITRO BY SECRETED PRODUCTS OF LOVO, A COLORECTAL-CANCER CELL-LINE
Intrasplenic vaccination against experimental melanoma